Clindex
Software DevelopmentMinnesota, United States2-10 Employees
Clindex® Clinical Trial Software A Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS) and Electronic Data Capture System (EDC) all in one powerful, integrated solution. Fortress Medical Systems was founded in 1997 with the launch of Clindex® [part of EvidentIQ Group since 2021], the first integrated clinical trial software system designed specifically for medical device trials. Over the years, Clindex® has been used to support not only medical device studies, but also pharmaceutical, diagnostic and combination product studies. By working closely with our customers, we have expanded the functionality of Clindex® so it is one of the most flexible and comprehensive systems on the market today. Our client base spans the world. As a testament to the scalability of Clindex®, our clients range from Fortune 500 corporations to small, start-up companies and include many contract Clinical Research Organizations (CROs) as well. Clindex® has been used in hundreds of studies, a large majority of which were to support marketing applications to the FDA. Clindex® EDC has been deployed worldwide with investigational sites spanning the globe. The FDA has audited studies conducted with Clindex® and to our knowledge no finding or deficiency has ever been attributed to Clindex®. Just as our software and client base have expanded over the years, so has our service offering. We offer services including implementation and configuration, database development, CTMS configuration and full Application Service Provider (ASP) services as a SaaS (Software as a Service) model. Our clients range from small start-up companies to Fortune 500 corporations. The US Centers for Disease Control and Prevention and many contract Clinical Research Organizations (CROs) use CLINDEX® for their studies. More than 90% of our clients over the past 10 years continue to use CLINDEX® today. For more information, please visit www.clindex.com.
1-888-653-2347 
support@leadiq.com 
